Neuropeptide Y: The Story, the Players, the Outcomes
Neuropeptide Y (NPY) is a peptide consisted of 36 amino acids. It is designated by a capital letter Y due to the presence of many tyrosine residues which are abbreviated by the letter Y in the single letter amino acid code. NPY is one of the most evolutio
- PDF / 6,293,648 Bytes
- 374 Pages / 439.37 x 666.142 pts Page_size
- 34 Downloads / 178 Views
.
Mia Levite Editor
Nerve-Driven Immunity Neurotransmitters and Neuropeptides in the Immune System
Editor Dr. Mia Levite Academic College of TLV Yaffo School of Behavioral Sciences Yaffo, Israel
This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically those of translation, reprinting, re-use of illustrations, broadcasting, reproduction by photocopying machines or similar means, and storage in data banks. Product Liability: The publisher can give no guarantee for all the information contained in this book. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. # 2012 Springer-Verlag/Wien SpringerWienNewYork is a part of Springer Science + Business Media springer.at Typesetting: SPi, Pondicherry, India Printed on acid-free and chlorine-free bleached paper SPIN: 12797301 With 70 Figures Library of Congress Control Number: 2012931322 ISBN 978-3-7091-0887-1 e-ISBN 978-3-7091-0888-8 DOI 10.1007/978-3-7091-0888-8 SpringerWienNewYork
Preface
Personal Recollection I still remember these moments very vividly, as if they were today, when at the corner of my eye I saw a lovely young woman waiting patiently for her turn to talk to me. She later turned out to be Dr. Claudia Panuschka – Springer’s Editor of Biomedicine/Life Sciences, whom I learned to appreciate professionally, and enjoyed so much working with. Claudia looked as if of she simply wishes to ask me a small question, at the end of my invited lecture on “Glutamate Immunity and Autoimmunity”, in an international meeting in Vienna, on Thursday, August 6th 2009. In that talk, I used a novel term – “Nerve-Driven Immunity” that I coined a few years before, and like so much using ever since, in papers and lectures, when discussing the relatively new concept of “Neurotransmitters in the Immune System”. When we were finally left alone, Claudia approached me gently, but not regarding a small matter as I thought. Rather, without any prior preparation or hesitation she threw to the air a huge idea that finally gave birth to this book: “As I enjoyed your talk and ideas so much, would you agree to write a book for Springer on ‘Nerve-Driven Immunity’?” she asked. This presumably simple question hit me by complete surprise, triggering a burst of fast inner thoughts: “Is she serious? . . . Can I do it? . . . Should I? . . . It could be a wonderful and unique opportunity to raise the awareness of people to this new important topic, which is to a large extent complementally unknown . . . a big challenge . . . a unique scientific and writing adventure . . . but . . . but at the same it would req
Data Loading...